Profile data is unavailable for this security.
About the company
Incanthera plc is a United Kingdom-based dermatology and oncology therapeutics company. The Company's is focused on developing a range of dermatological applications utilizing its unique formulation and delivery technologies to meet the unmet needs in the skincare market. Skin + CELL is the Company’s luxury skincare brand utilizing the advanced formulation and delivery expertise, to bring scientifically proven formulations to cosmetics. Skin + CELL's formulations, enriched with targeted bioactive B3 (an activated form of niacinamide) are delivered directly into the skin's cells to optimize and protect cellular health, energy and protective capabilities. Skin + CELL's luxury skincare range extends across face, body, hand, face serum and eye serum.
- Revenue in GBP (TTM)0.00
- Net income in GBP-1.55m
- Incorporated2017
- Employees7.00
- LocationIncanthera PLC76 King StreetMANCHESTER M2 4NHUnited KingdomGBR
- Phone+44 161 817 5005
- Websitehttp://www.incanthera.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OptiBiotix Health PLC | 569.00k | -2.98m | 13.71m | 5.00 | -- | 1.86 | -- | 24.10 | -0.0317 | -0.0317 | 0.0061 | 0.0752 | 0.0634 | 1.35 | 1.07 | 113,800.00 | -33.25 | 16.82 | -34.85 | 17.52 | 47.98 | 53.03 | -524.43 | 183.49 | 5.36 | -2.03 | 0.00 | 100.14 | 40.92 | 4.60 | -178.82 | -- | -- | -- |
Hemogenyx Pharmaceuticals PLC | 0.00 | -5.18m | 17.44m | 17.00 | -- | 5.69 | -- | -- | -0.0042 | -0.0042 | 0.00 | 0.0023 | 0.00 | -- | -- | 0.00 | -77.79 | -82.19 | -85.95 | -95.97 | -- | -- | -- | -- | -- | -19.94 | 0.4794 | -- | -- | -- | -68.14 | -- | 36.68 | -- |
Skinbiotherapeutics PLC | 161.65k | -2.88m | 25.43m | 11.00 | -- | 5.87 | -- | 157.34 | -0.0165 | -0.0165 | 0.0009 | 0.0192 | 0.0522 | 0.8871 | 0.4181 | 14,695.45 | -93.07 | -52.07 | -115.26 | -57.33 | 62.90 | -- | -1,784.70 | -4,694.37 | 6.48 | -379.78 | 0.0259 | -- | 76.65 | -- | -1.52 | -- | 18.00 | -- |
Arecor Therapeutics PLC | 4.90m | -8.67m | 26.05m | 50.00 | -- | 4.16 | -- | 5.32 | -0.283 | -0.283 | 0.16 | 0.1658 | 0.3213 | -- | 1.67 | 97,980.00 | -56.84 | -- | -89.06 | -- | -- | -- | -176.89 | -- | 1.27 | -- | 0.0523 | -- | 90.30 | -- | 7.62 | -- | -- | -- |
Incanthera PLC | 0.00 | -1.55m | 26.89m | 7.00 | -- | -- | -- | -- | -0.0189 | -0.0189 | 0.00 | -0.0061 | 0.00 | -- | -- | 0.00 | -852.34 | -115.31 | -- | -153.87 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -12.76 | -- | -- | -- |
Sareum Holdings Plc | 0.00 | -4.26m | 30.22m | 5.00 | -- | 47.18 | -- | -- | -0.0614 | -0.0614 | 0.00 | 0.0059 | 0.00 | -- | -- | 0.00 | -160.20 | -71.41 | -195.05 | -81.48 | -- | -- | -- | -19,709.24 | -- | -6.61 | 0.00 | -- | -- | -- | -46.96 | -- | -- | -- |
Shield Therapeutics PLC | 20.88m | -36.17m | 32.06m | 73.00 | -- | 59.27 | -- | 1.54 | -0.0477 | -0.0477 | 0.0274 | 0.0007 | 0.4723 | 4.06 | 1.69 | 286,068.50 | -81.80 | -56.68 | -136.41 | -67.44 | 34.65 | 52.20 | -173.18 | -365.89 | 0.8968 | -15.29 | 0.9736 | -- | 137.95 | 1.95 | 33.13 | -- | -2.50 | -- |
Poolbeg Pharma PLC | 0.00 | -4.38m | 38.75m | 8.00 | -- | 3.11 | -- | -- | -0.0088 | -0.0088 | 0.00 | 0.0249 | 0.00 | -- | -- | 0.00 | -29.11 | -- | -30.18 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 16.11 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Odd Asset Management Ltd.as of 21 Jun 2024 | 21.67m | 18.57% |
Unicorn Asset Management Ltd.as of 21 Jun 2024 | 13.33m | 11.43% |